ABU DHABI: The fifth Abu Dhabi Medical Congress (ADMC), which opened on Sunday at the Abu Dhabi National Exhibition Centre (Adnec), was officially inaugurated by Zaid Al Siksek, CEO, Health Authority – Abu Dhabi.
The event continues until Tuesday and is expected to attract more than 5,000 professionals working in the primary healthcare, emergency, patient safety, rehabilitation and pharma sectors across the region.
Simon Page, managing director, Life Sciences, Informa Exhibitions, said: “The success of the healthcare reforms in Abu Dhabi has been striking and many trends such as greater private involvement in healthcare provision, increased use of ICT, and better public health awareness are set to continue.
Meanwhile, capacity will need to expand considerably to keep pace with the growth. All of these issues present challenges, but given the resources available and the long-term strategic planning in place, they are outweighed by the huge opportunities for the Emirates and health investors alike.”
Abu Dhabi Health Services Company (Seha), the main partner at ADMC, is expecting to network with patients and stakeholders, as well as answer questions, inform, take suggestions and complaints.
Looking ahead to the expected growth of private sector involvement in the healthcare in the UAE, Al Mazrouei, acting manager corporate marketing, Seha, feels that the ADMC brings focus on the vibrancy of the healthcare marketplace in the region, especially in Abu Dhabi.
Alongside the exhibition runs a comprehensive congress programme carefully planned to discuss current goals, review tools for implementation, and meet the challenges of new and emerging healthcare dilemmas in the region. Ten different CME accredited congresses with a panel of more than 250 international speakers analyse the current best approaches for each sector involved in the congress over the next few days.
New for this year is the “Current Trends in Pharmaceuticals and Biotechnology Conference” that kicked off on Sunday with current medical updates and regulations for pharmaceutical products in the UAE, lead by Dr Yasser Sharif, section head-medication safety and medical product safety, Health Authority-Abu Dhabi.
|